NCT02242292View on ClinicalTrials.gov

Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort

PHASE2CompletedINTERVENTIONAL
Enrollment

527

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2007

Conditions
Colic
Interventions
DRUG

Hyoscine butylbromide

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02242292 - Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort | Biotech Hunter | Biotech Hunter